743.76 - 757.57
479.80 - 796.25
8.25M / 11.73M (Avg.)
27.40 | 27.58
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
16.05%
Revenue growth at 50-75% of BIDU's 23.58%. Martin Whitman would worry about competitiveness or product relevance.
17.62%
Gross profit growth at 50-75% of BIDU's 34.40%. Martin Whitman would question if cost structure or brand is lagging.
32.28%
EBIT growth below 50% of BIDU's 109.91%. Michael Burry would suspect deeper competitive or cost structure issues.
32.28%
Operating income growth under 50% of BIDU's 109.91%. Michael Burry would be concerned about deeper cost or sales issues.
27.17%
Net income growth under 50% of BIDU's 148.45%. Michael Burry would suspect the firm is falling well behind a key competitor.
26.42%
EPS growth under 50% of BIDU's 144.83%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
26.92%
Diluted EPS growth under 50% of BIDU's 143.10%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.30%
Slight or no buybacks while BIDU is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.24%
Slight or no buyback while BIDU is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
5.97%
OCF growth under 50% of BIDU's 59.38%. Michael Burry might suspect questionable revenue recognition or rising costs.
3.41%
FCF growth under 50% of BIDU's 80.09%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
767.65%
10Y revenue/share CAGR under 50% of BIDU's 4990.46%. Michael Burry would suspect a lasting competitive disadvantage.
401.78%
5Y revenue/share CAGR 1.25-1.5x BIDU's 285.37%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
183.05%
3Y revenue/share CAGR above 1.5x BIDU's 76.03%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
3361.63%
OCF/share CAGR of 3361.63% while BIDU is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
1311.73%
OCF/share CAGR of 1311.73% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
253.21%
3Y OCF/share CAGR of 253.21% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
1250.34%
Below 50% of BIDU's 2944.62%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
1679.26%
5Y net income/share CAGR above 1.5x BIDU's 60.56%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
336.24%
3Y net income/share CAGR above 1.5x BIDU's 25.82%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
218.39%
5Y equity/share CAGR at 50-75% of BIDU's 396.65%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
220.23%
3Y equity/share CAGR above 1.5x BIDU's 124.53%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.11%
AR growth is negative/stable vs. BIDU's 29.61%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
No Data
No Data available this quarter, please select a different quarter.
7.46%
Asset growth at 75-90% of BIDU's 8.30%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
6.59%
1.25-1.5x BIDU's 5.10%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
4.63%
R&D dropping or stable vs. BIDU's 11.05%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
3.04%
SG&A growth well above BIDU's 4.15%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.